State of Alaska Department of Revenue’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-29,542
| Closed | -$217K | – | 1616 |
|
2023
Q2 | $217K | Sell |
29,542
-862
| -3% | -$6.33K | ﹤0.01% | 1590 |
|
2023
Q1 | $314K | Sell |
30,404
-513
| -2% | -$5.3K | ﹤0.01% | 1531 |
|
2022
Q4 | $365K | Buy |
30,917
+193
| +0.6% | +$2.28K | ﹤0.01% | 1481 |
|
2022
Q3 | $644K | Sell |
30,724
-3,101
| -9% | -$65K | 0.01% | 1169 |
|
2022
Q2 | $1.05M | Buy |
33,825
+430
| +1% | +$13.3K | 0.01% | 934 |
|
2022
Q1 | $1.37M | Sell |
33,395
-510
| -2% | -$20.9K | 0.01% | 828 |
|
2021
Q4 | $1.47M | Buy |
33,905
+26,367
| +350% | +$1.15M | 0.01% | 864 |
|
2021
Q3 | $377K | Buy |
7,538
+506
| +7% | +$25.3K | ﹤0.01% | 1543 |
|
2021
Q2 | $442K | Sell |
7,032
-65
| -0.9% | -$4.09K | ﹤0.01% | 1488 |
|
2021
Q1 | $659K | Sell |
7,097
-223
| -3% | -$20.7K | 0.01% | 1283 |
|
2020
Q4 | $655K | Sell |
7,320
-339
| -4% | -$30.3K | 0.01% | 1207 |
|
2020
Q3 | $791K | Sell |
7,659
-34,378
| -82% | -$3.55M | 0.01% | 1003 |
|
2020
Q2 | $3.32M | Buy |
42,037
+1,330
| +3% | +$105K | 0.04% | 449 |
|
2020
Q1 | $2.36M | Buy |
40,707
+7,570
| +23% | +$438K | 0.04% | 458 |
|
2019
Q4 | $1.79M | Sell |
33,137
-560
| -2% | -$30.2K | 0.02% | 621 |
|
2019
Q3 | $1.76M | Buy |
33,697
+18,299
| +119% | +$956K | 0.02% | 589 |
|
2019
Q2 | $743K | Buy |
15,398
+209
| +1% | +$10.1K | 0.01% | 881 |
|
2019
Q1 | $767K | Buy |
15,189
+200
| +1% | +$10.1K | 0.01% | 843 |
|
2018
Q4 | $888K | Buy |
14,989
+737
| +5% | +$43.7K | 0.02% | 693 |
|
2018
Q3 | $938K | Buy |
14,252
+2,681
| +23% | +$176K | 0.02% | 756 |
|
2018
Q2 | $584K | Buy |
11,571
+250
| +2% | +$12.6K | 0.01% | 975 |
|
2018
Q1 | $596K | Buy |
11,321
+4,340
| +62% | +$228K | 0.01% | 856 |
|
2017
Q4 | $324K | Buy |
6,981
+70
| +1% | +$3.25K | 0.01% | 998 |
|
2017
Q3 | $279K | Buy |
6,911
+40
| +0.6% | +$1.62K | 0.01% | 882 |
|
2017
Q2 | $232K | Buy |
6,871
+3,051
| +80% | +$103K | 0.02% | 795 |
|
2017
Q1 | $110K | Buy |
3,820
+100
| +3% | +$2.88K | 0.01% | 906 |
|
2016
Q4 | $122K | Buy |
+3,720
| New | +$122K | 0.01% | 587 |
|